Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1110905

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1110905

Global Digital Pharmacy Market- By Drug Type, By Product, By Platform, By Business Model, By Geographic Coverage- Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

PUBLISHED:
PAGES: 238 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

According to SPER Market Research, the Digital Pharmacy Market is estimated to reach USD 334.25 billion by 2030 with a CAGR of 16.8%.

The rising consumer desire for purchasing pharmaceuticals online during and after the COVID-19 pandemic, market consolidation and partnerships, and the rising elderly population all contribute to the sector's growth. During the projected period, an increasing number of violent pharmacies and patients who depend on pharmacists for therapeutic support are anticipated to hinder the growth of this market.

Impact of COVID-19 on the Global Digital Pharmacy Market

Other significant reasons boosting the market growth include the expanding number of internet users, more access to online services, and the increased deployment of e-prescriptions in healthcare services in the aftermath of the COVID-19 epidemic. In March 2020, CVS Health began implementing new strategies to balance the demand for medications used throughout the treatment of both COVID-19 and other chronic conditions. In November 2020, Amazon will start an online pharmacy service in the United States for both generic and prescription pharmaceuticals. Before COVID-19, 70% of families were chronic-first consumers of digital pharmacy because they saw superior value in these affordable and convenient services. Nevertheless, as digital pharmacy proved the need of the hour during the lockdown period, an identical amount of chronic-first and acute-first families were onboarded. Furthermore, the rising demand for over-the-counter (OTC) items such as masks, sanitizers, thermometers, and steamers, among others, is supporting the expansion of the digital pharmacy market. As a result, the rapid use of OTC products will benefit the digital pharmacy sector.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Drug Type, By Product, By Platform, By Business Model, By Geographic Coverage
  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: Amazon.com Inc., Apex Pharmacy, Apollo Pharmacy, Cigna, Costco Wholesale Corporation, CVS Health, DocMorris, Giant Eagle Inc., GoodRx, HealthWarehouse Inc., Hims & Hers Health Inc., Lloyds Pharmacy, Netmeds.com, NorthWestPharmacy.com, Optum Inc., PharmEasy, Pharmex Direct Inc., Rexall Pharmacy Group ULC, Rite Aid Corp., Ro Pharmacy, Rx Outreach, Shop-apotheke.com, Tata 1mg, TELUS, The Independent Pharmacy, The Kroger Co., Walgreen Co., Walmart Inc.

Global Digital Pharmacy Market, By Drug Type:

Based on the Drug Type, Global Digital Pharmacy Market is segmented as; Over-The-Counter Products (Ease of use and convenience associated with Over-The-Counter products to drive market growth), Prescription Medicines (Growing geriatric population and subsequent increase in chronic diseases to drive the demand for prescription medication).

Global Digital Pharmacy Market, By Product:

Based on the Product, Global Digital Pharmacy Market is segmented as; Medicines and Treatments {Diabetes Care (Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments), Heart Care (Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments), Oncology (Increasing prevalence of cancer is a major factor driving the growth of this market segment, Other medicines & treatments)}, Vitamins and Supplements (Growing demand for immunity-associated supplements in the wake of the COVID-19 pandemic to drive market growth), Personal Care Products (Growing focus on personal health & hygiene to drive market growth), Other Products.

Global Digital Pharmacy Market, By Platform:

Based on the Platform, Global Digital Pharmacy Market is segmented as; Applications (AAPS) (Advantages such as contactless delivery will drive the demand for AAPS), Websites (Promotions, discounts, and offers provided by websites to drive market growth).

Global Digital Pharmacy Market, By Business Model:

Based on the Business Model, Global Digital Pharmacy Market is segmented as; Captive (Flexibility, accessibility, and affordability of captive models-key factors driving market growth), Aggregator (Quality services associated with aggregator models to drive market growth), Franchise (Growing number of pharmacy franchises to drive market growth).

Global Digital Pharmacy Market, By Geographic Coverage:

Based on the Geographic Coverage, Global Digital Pharmacy Market is segmented as; Urban Areas (Rapid internet penetration in urban areas to drive market growth in this segment), Rural Areas (Government initiatives to fuel the demand for digital pharmacies in rural areas).

Global Digital Pharmacy Market, By Region:

North America owns the prime share of this market; the major factors of the market's growth in the region are the increasing incidence of chronic illnesses, the growing amount of medicine prescriptions brought on by the region's rapidly aging population, and the expansion of key market participants in the area.

Product Code: PHAR2207

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Digital Pharmacy Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Digital Pharmacy Market, By Drug Type, 2019-2030 (USD Million)

  • 6.1. Over-The-Counter Products
    • 6.1.1. Ease of use and convenience associated with Over-The-Counter products to drive market growth
  • 6.2. Prescription Medicines
    • 6.2.1. Growing geriatric population and subsequent increase in chronic diseases to drive the demand for prescription medication

7. Global Digital Pharmacy Market, By Product, 2019-2030 (USD Million)

  • 7.1. Medicines and Treatments
    • 7.1.1. Diabetes Care
      • 7.1.1.1 Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments
    • 7.1.2. Heart Care
      • 7.1.2.1 Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments
    • 7.1.3. Oncology
      • 7.1.3.1 Increasing prevalence of cancer is a major factor driving the growth of this market segment
      • 7.1.3.2 Other medicines & treatments
  • 7.2. Vitamins and Supplements
    • 7.2.1 Growing demand for immunity-associated supplements in the wake of the Covid-19 pandemic to drive market growth
  • 7.3. Personal Care Products
    • 7.3.1 Growing focus on personal health & hygiene to drive market growth
  • 7.4. Other Products

8. Global Digital Pharmacy Market, By Platform, 2019-2030 (USD Million)

  • 8.1. Applications (AAPS)
    • 8.1.1 Advantages such as contactless delivery will drive the demand for AAPS
  • 8.2. Websites
    • 8.2.1 Promotions, discounts, and offers provided by websites to drive market growth

9. Global Digital Pharmacy Market, By Business Model, 2019-2030 (USD Million)

  • 9.1. Captive
    • 9.1.1 Flexibility, accessibility, and affordability of captive models-key factors driving market growth
  • 9.2. Aggregator
    • 9.2.1 Quality services associated with aggregator models to drive market growth
  • 9.3. Franchise
    • 9.3.1 Growing number of pharmacy franchises to drive market growth

10. Global Digital Pharmacy Market, By Geographic Coverage, 2019-2030 (USD Million)

  • 10.1 Urban Areas
    • 10.1.1 Rapid internet penetration in urban areas to drive market growth in this segment
  • 10.2 Rural Areas
    • 10.2.1 Government initiatives to fuel the demand for digital pharmacies in rural areas

11. Global Digital Pharmacy Market, By Region, 2019-2030 (USD Million)

  • 11.1 North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2 Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4 South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5 Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1 Amazon.com Inc.
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2 Apex Pharmacy
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3 Apollo Pharmacy
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4 Cigna
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5 Costco Wholesale Corporation
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6 CVS Health
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7 DocMorris
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8 Giant Eagle Inc.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9 GoodRx
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10 HealthWarehouse Inc.
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11 Hims & Hers Health Inc.
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12 Lloyds Pharmacy
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13 Netmeds.com
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14 NorthWestPharmacy.com
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15 Optum Inc.
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16 PharmEasy
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17 Pharmex Direct Inc.
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18 Rexall Pharmacy Group ULC
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19 Rite Aid Corp.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20 Ro Pharmacy
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21 Rx Outreach
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22 Shop-apotheke.com
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23 Tata 1mg
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24 TELUS
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments
  • 12.25 The Independent Pharmacy
    • 12.25.1. Company details
    • 12.25.2. Financial outlook
    • 12.25.3. Product summary
    • 12.25.4. Recent developments
  • 12.26 The Kroger Co.
    • 12.26.1. Company details
    • 12.26.2. Financial outlook
    • 12.26.3. Product summary
    • 12.26.4. Recent developments
  • 12.27 Walgreen Co.
    • 12.27.1. Company details
    • 12.27.2. Financial outlook
    • 12.27.3. Product summary
    • 12.27.4. Recent developments
  • 12.28 Walmart Inc.
    • 12.28.1. Company details
    • 12.28.2. Financial outlook
    • 12.28.3. Product summary
    • 12.28.4. Recent developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!